Page 7 - Esperion Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Esperion therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Esperion Therapeutics Today - Breaking & Trending Today

Analysts Set Esperion Therapeutics, Inc. (NASDAQ:ESPR) Price Target at $9.33

Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has received a consensus recommendation of “Hold” from the five research firms that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among […] ....

United States , Needham Company , Esperion Therapeutics Company Profile , Capital Partners , Connor Clark Lunn Investment Management Ltd , Esperion Therapeutics Inc , Armistice Capital , Esperion Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Stock Down , Asset Management , Connor Clark , Lunn Investment Management , Get Free , Esperion Therapeutics Daily , Nasdaq Espr ,

PSI Advisors LLC Has $51,000 Position in Esperion Therapeutics, Inc. (NASDAQ:ESPR)

PSI Advisors LLC lifted its stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 161.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,500 shares during the […] ....

United States , New York , Pinnacle Associates Ltd , Simplicity Solutions , Esperion Therapeutics Inc , Psi Advisors , Exchange Commission , Chicago Partners Investment Group , Needham Company , Jacob Asset Management Of New York , Esperion Therapeutics , Free Report , Partners Investment Group , Asset Management , Monaco Asset Management , Get Free Report , Esperion Therapeutics Daily , Nasdaq Espr , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Newest Indication for Bempedoic Acid Expands Patient Population

In March 2024, the label for bempedoic acid was expanded to reduce cardiovascular risk and expand the low-density lipoprotein-C (LDL-C) lowering in both primary and secondary prevention patients. ....

United States , Knight Cardiovascular Institute At Oregon Health , Science University , American College Of Cardiology , Pharmacy Times , Bruce Warden , Knight Cardiovascular Institute , Oregon Health , Esperion Therapeutics , American College ,